# Lactic Acid Drives ESM1 to Attenuate DNA Damage and CD8+ T Cell Infiltration in Cancer

**Authors:** Yingzheng Tan, Jiao Xiao, Liyun Tang, Jian Wan, Tian Zeng, Wenchao Zhou, Xueru Liu, Xun Chen, Yukun Li

PMC · DOI: 10.32604/or.2026.071536 · Oncology Research · 2026-03-23

## TL;DR

Lactic acid helps cancer cells repair DNA damage and avoid immune detection by activating specific pathways involving ESM1 and Akt1.

## Contribution

The study reveals a novel mechanism by which lactate promotes DNA repair and immune evasion in cancer cells through ESM1 and Akt1.

## Key findings

- Lactate increases ESM1 expression and reduces DNA damage in tumor cells.
- Lactate suppresses DNA damage response by activating Akt1 and inhibiting the cGAS pathway.
- ESM1 knockout enhances CD8+ T cell infiltration and tumor cell apoptosis in mice.

## Abstract

Lactate, as a critical byproduct of tumor metabolic reprogramming, plays an important role in DNA damage repair and tumor immune infiltration. This work aims to elucidate the molecular mechanisms by which lactate promotes tumor DNA damage repair (DDR) and subsequent immune evasion.

Hepatocellular carcinoma (HCC), lung adenocarcinoma (LUAD), and ovarian cancer (OC) cells with cisplatin-induced DNA damage were treated with lactate at a concentration gradient, Endothelial cell-specific molecule 1 (ESM1) shRNA, ESM1 overexpression plasmid, or the Protein Kinase B (AKT) Serine/Threonine Kinase 1 (Akt1) inhibitor LY294002. Proliferation, apoptosis, and DNA damage levels were assessed using 5-ethynyl-2′-deoxyuridine (EdU) staining, flow cytometry-based apoptosis assay, and comet assay. Western blot (WB), Polymerase Chain Reaction (PCR), and immunofluorescence (IF) were employed to evaluate the effects of lactate on the expression of ESM1, Akt1, and Cyclic GMP-AMP Synthase (cGAS) pathway-related proteins in cancer cells. Xenograft tumor models were established using ESM1 whole-gene knockout mice, and Cluster of Differentiation 8 Positive (CD8+) T cell infiltration and apoptotic levels in tumors were detected via flow cytometry. Immunohistochemistry (IHC) was performed to examine the expression of ESM1, double-stranded DNA (dsDNA), and CD8 in tumor patient samples, followed by correlation analysis.

This study demonstrates that lactate increases ESM1 mRNA and protein expression in a concentration-dependent manner and reduces DNA damage in tumor cells. Lactate suppresses DDR by activating the Akt1 signaling pathway via ESM1 and further inhibits the cGAS pathway, thereby downregulating the transcription of chemokines and pro-inflammatory factors. In vivo experiments confirm that ESM1 knockout promotes CD8+ T cell infiltration into tumors and induces apoptosis. Analysis of tumor patient samples further validates the negative correlation between ESM1 and CD8+ T cell levels in cancer patients.

In summary, lactate activates the Akt1-Murine Double Minute 2 (MDM2)-p53 pathway via ESM1 to suppress DDR, while the reduction of DDR-generated dsDNA inactivates the cyclic GMP-AMP synthase–Stimulator of Interferon Genes (cGAS-STING) pathway, thereby inhibiting CD8+ T cell immune infiltration.

## Linked entities

- **Genes:** ESM1 (endothelial cell specific molecule 1) [NCBI Gene 11082], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004], MDM2 (MDM2 proto-oncogene) [NCBI Gene 4193], TP53 (tumor protein p53) [NCBI Gene 7157]
- **Proteins:** ESM1 (endothelial cell specific molecule 1), AKT1 (AKT serine/threonine kinase 1), CD8A (CD8 subunit alpha)
- **Chemicals:** lactate (PubChem CID 61503), cisplatin (PubChem CID 5460033), LY294002 (PubChem CID 3973)
- **Diseases:** hepatocellular carcinoma (MONDO:0007256), lung adenocarcinoma (MONDO:0005061), ovarian cancer (MONDO:0005140)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, MDM2 (MDM2 proto-oncogene) [NCBI Gene 4193] {aka ACTFS, HDMX, LSKB, hdm2}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, ESM1 (endothelial cell specific molecule 1) [NCBI Gene 11082] {aka endocan}
- **Diseases:** LUAD (MESH:D000077192), Cancer (MESH:D009369), HCC (MESH:D006528), OC (MESH:D010051), inflammatory (MESH:D007249)
- **Chemicals:** Lactate (MESH:D019344), 5-ethynyl-2'-deoxyuridine (MESH:C031086), LY294002 (MESH:C085911), cisplatin (MESH:D002945)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13040346/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13040346/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC13040346/full.md

---
Source: https://tomesphere.com/paper/PMC13040346